In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 75 for your search:
Drug:  etoposide phosphate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV, Phase III
Type: Treatment
Status: Unknown
Age: 21 and under
Sponsor: Other
Protocol IDs: GPOH-NB2004, EU-20661, NCT00410631

2.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-00055-18, NCT00415103

3.

Phase: Phase IV
Type: Biomarker/Laboratory analysis
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: FWA00015357, NPI - 1831468511, NPI - 1023387701, IRB00009424, IORG0007849, NCT01064466

4.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: IFCT-0802, 2009-010187-42, NCT00930891

5.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CC-5013-DLC-001, NCT01197560

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 and under
Sponsor: Other
Protocol IDs: EBMT-RANDOM-ICE, EU-98001, NCI-V01-1645, NCT00011921

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Under 1
Sponsor: Other
Protocol IDs: CCLG-NB-1999-03, EU-20597, NCT00417053

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: CCLG-GC-1997-01, EU-20579, SIOP-CNS-GCT-96, NCT00293358

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 to under 30
Sponsor: NCI, Other
Protocol IDs: AALL0433, NCI-2009-00306, COG-AALL0433, CDR0000495359, U10CA098543, NCT00381680

10.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000531141, CRUK-LUNGSTAR, EU-20649, ISRCTN56306957, EUDRACT-2005-005821-71, UCL-BRD/05/129, MREC-06-MRE10-28, CTA-20363-0215-001, CTAAC-C1312-A5335, CTAAC-C1312-A12462, NCT00433498

11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 21 and under at the time of definitive surgery
Sponsor: NCI, Other
Protocol IDs: ACNS0333, NCI-2009-00337, CDR0000592812, COG-ACNS0333, U10CA098543, NCT00653068

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: D0750018, NCT00660504

13.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: 1 to 18
Sponsor: Other
Protocol IDs: CCLG-ALLR3, CCLG-ALLR3, ISCRTN-45724312, EUDRACT-2004-000052-16, EU-20938, NCT00967057

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CPMC-IRB-7866, NCI-G97-1327, NCT00003064

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: Other
Protocol IDs: CLO21800205, NCT00315705

16.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: PSHCI 08-005, NCT00702962

17.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 1 to 25
Sponsor: NCI, Other
Protocol IDs: 07053, P30CA033572, CHNMC-07053, CA180 121, CDR0000617760, NCT00788125

18.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20060534, NCT00791154

19.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Other
Protocol IDs: 10-0910 / 201106039, NCT00906945

20.

Phase: Phase II
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CWRU4196, P30CA043703, BMS-CRWU-4196, NCI-G00-1854, NCT00006260

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 30 and under at original diagnosis
Sponsor: NCI, Other
Protocol IDs: ANBL00P1, COG-ANBL00P1, CDR0000068681, NCT00017368

22.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000276590, U10CA021115, E5501, ECOG-5501, NCT00057837

23.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 59
Sponsor: Other
Protocol IDs: LL03, NCT00195871

24.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: Other
Protocol IDs: CNS 0294, NCT00179920

25.

Phase: Phase II
Type: Treatment
Status: Unknown
Age: 16 and over
Sponsor: Other
Protocol IDs: MRC-TE23, EU-205107, ISRCTN53643604, EUDRACT-2004-000405-22, NCT00301782
1    
New Search